Bevacizumab Reduced Incidence of Postoperative Recurrent Vitreous Hemorrhage in Small Study
One intravitreal injection of bevacizumab (Avastin,
Genentech) reduced the incidence of recurrent postoperative
vitreous hemorrhage after diabetic vitrectomy,
according to a study in Retina.1
Rizwan A. Cheema, MD, FRCS, FRCOphth, of the
Dhahran Eye Specialist Hospital, Saudi Arabia, and colleagues
conducted a retrospe...